Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026)
Johnson & Johnson recorded quarterly Cash & Current Investments of $22.1 billion in Q1 2026, up 9.7% quarter-over-quarter from $20.1 billion in Q4 2025, and down 43.14% year-over-year from $38.8 billion in Q1 2025.
Johnson & Johnson's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $22.1 billion for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 43.14% year-over-year to $22.1 billion; the TTM figure through Mar 2026 stood at $22.1 billion (down 43.14% YoY), while the FY2025 annual figure was $20.1 billion, down 18.02% from the prior year.
- Cash & Current Investments came in at $22.1 billion for Q1 2026 at Johnson & Johnson, up from $20.1 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $38.8 billion in Q1 2025 to a low of $18.6 billion in Q3 2025.
- A 5-year average of $25.9 billion and a median of $24.6 billion in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments surged 47.92% in 2025 and slumped 43.14% in 2026, its largest moves.
- Johnson & Johnson's Cash & Current Investments stood at $34.1 billion in 2022, then plunged by 32.72% to $22.9 billion in 2023, then advanced by 6.96% to $24.5 billion in 2024, then retreated by 18.02% to $20.1 billion in 2025, then climbed by 9.7% to $22.1 billion in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $22.1 billion, $20.1 billion, and $18.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.70 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 13.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 10.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 22.05 Bn |
| Dec 28, 2025 | 20.10 Bn |
| Sep 28, 2025 | 18.56 Bn |
| Jun 29, 2025 | 18.88 Bn |
| Mar 30, 2025 | 38.78 Bn |
| Dec 29, 2024 | 24.52 Bn |
| Sep 29, 2024 | 20.30 Bn |
| Jun 30, 2024 | 25.48 Bn |
| Mar 31, 2024 | 26.22 Bn |
| Dec 31, 2023 | 22.93 Bn |
| Oct 1, 2023 | 23.51 Bn |
| Jul 2, 2023 | 28.51 Bn |
| Apr 2, 2023 | 24.61 Bn |
| Jan 1, 2023 | 22.28 Bn |
| Oct 2, 2022 | 34.08 Bn |
| Jul 3, 2022 | 32.57 Bn |
| Apr 3, 2022 | 30.39 Bn |
| Jan 2, 2022 | 31.61 Bn |
| Oct 3, 2021 | 31.00 Bn |
| Jul 4, 2021 | 25.31 Bn |
| Apr 4, 2021 | 24.62 Bn |
| Jan 3, 2021 | 25.19 Bn |
| Sep 27, 2020 | 30.78 Bn |
| Jun 28, 2020 | 19.14 Bn |
| Mar 29, 2020 | 18.02 Bn |
| Dec 29, 2019 | 19.29 Bn |
| Sep 29, 2019 | 17.95 Bn |
| Jun 30, 2019 | 15.28 Bn |
| Mar 31, 2019 | 15.34 Bn |
| Dec 30, 2018 | 19.69 Bn |
| Sep 30, 2018 | 19.36 Bn |
| Jul 1, 2018 | 18.14 Bn |
| Apr 1, 2018 | 15.20 Bn |
| Dec 31, 2017 | 18.30 Bn |
| Oct 1, 2017 | 16.23 Bn |
| Jul 2, 2017 | 12.85 Bn |
| Apr 2, 2017 | 39.34 Bn |
| Jan 1, 2017 | 41.91 Bn |
| Oct 2, 2016 | 40.43 Bn |
| Jul 3, 2016 | 42.58 Bn |
| Apr 3, 2016 | 39.86 Bn |
| Jan 3, 2016 | 38.38 Bn |
| Sep 27, 2015 | 37.31 Bn |
| Jun 28, 2015 | 33.95 Bn |
| Mar 29, 2015 | 31.32 Bn |
| Dec 28, 2014 | 33.09 Bn |
| Sep 28, 2014 | 33.01 Bn |
| Jun 29, 2014 | 31.62 Bn |
| Mar 30, 2014 | 29.39 Bn |
| Dec 29, 2013 | 29.21 Bn |
| Sep 29, 2013 | 25.23 Bn |
| Jun 30, 2013 | 25.13 Bn |
| Mar 31, 2013 | 21.67 Bn |
| Dec 30, 2012 | 21.09 Bn |
| Sep 30, 2012 | 19.77 Bn |
| Jul 1, 2012 | 16.92 Bn |
| Apr 1, 2012 | 33.85 Bn |
| Jan 1, 2012 | 32.26 Bn |
| Oct 2, 2011 | 30.93 Bn |
| Jul 3, 2011 | 29.68 Bn |
| Apr 3, 2011 | 26.87 Bn |
| Jan 2, 2011 | 27.66 Bn |
| Oct 3, 2010 | 22.13 Bn |
| Jul 4, 2010 | 18.90 Bn |
| Apr 4, 2010 | 18.01 Bn |
| Jan 3, 2010 | 19.43 Bn |
| Sep 27, 2009 | 14.34 Bn |
| Jun 28, 2009 | 14.72 Bn |
| Mar 29, 2009 | 12.59 Bn |